News Releases

Campaign Aims to Raise TB Awareness and Funds to Fight Lung Disease

Revolutionary Tuberculosis Test Brings Accurate, Faster Results to U.S. Market

Record Revenue Driven by $18 Million Year-Over-Year Growth in Clinical

Record Revenue Highlights Strong Demand and Progress in Manufacturing, But Unanticipated Inventory Reserve Increases Costs

Test for Direct Identification of MRSA and Staphylococcus aureus from Positive Blood Cultures Includes Updates & Expanded Claims

Clinical Reagent Revenue Growth of 23% Driven by Continued Momentum of Xpert® Test Portfolio

Clinical Reagents Grow 32% in 2012

Xpert CT/NG Makes Same-Day Consultation and Treatment Possible for Two Most Common STDs

Preliminary Q4 2012 Revenue of Approximately $92 Million Reflects Stronger Than Expected Commercial Clinical Performance Offset By Lower HBDC

Rapid, On-Demand Results Deliver New Confidence in Same-Day Patient Consultation and Treatment

Xpert® Cartridge Backorders to Ship in October, Full Year Revenue Guidance Unchanged

CE-IVD Test Now Incorporates Lot-Specific Standardization Using WHO Standards

Industry's Highest Throughput System Capable of More Than 2,000 Daily Test Results

90-Minute On-Demand Results Deliver New Confidence in Same-Day Patient Consultation and Treatment

National Institutes of Health Awards $1.3 Million of Expected Five-Year, $5.5 Million Project

Record GeneXpert® System Placements Contribute to 39% Growth in Clinical Business

Record Revenue Driven by 33% Growth in Clinical Molecular Diagnostics

CE IVD Test Now Delivers Results Aligned to the International Scale

Redesigned GeneXpert Family Expands to Include Two-Module and Infinity-80 Systems

Record GeneXpert® System Placements Contribute to Record Revenue